Boletín mensual de la agencia británica, Medicines and Healthcare
products Regulatory Agency y su comiité asesor Commission on Human
Medicines
18 de diciembre , 2014
Contenido
Drug safety advice
Ivabradine (Procoralan) in the symptomatic treatment of angina: risk of cardiac side effects—new advice to minimise risk A1
Isotretinoin (Roaccutane): reminder of possible risk of psychiatric
disorders — warn patients and family; monitor patients for signs of
depression A2
Hydroxyethyl starch intravenous infusions to be used only in patients
with acute blood loss and when crystalloids alone are not sufficient A3
Hydrogen peroxide: reminder of risk of gas embolism when used in surgery
–do not use in closed body cavities or on deep or large wounds A4
Veletri (epoprostenol) powder for solution for infusion: incompatibilities with some models of administration devices A5
otra información de MHRA
Drug Safety Update is moving to GOV.UK O1
http://www.mhra.gov.uk/home/groups/dsu/documents/publication/con491148.pdf
No hay comentarios:
Publicar un comentario